Levaquin is a popular antibiotic commonly used to treat infections such as respiratory and urinary tract infections. It is part of a class of antibiotics known as fluoroquinolones. Levaquin was approved by the FDA in December of 1998. It and other fluoroquinolones are now used by 26 million Americans each year. Two independent medical studies were published in 2015, one in the Journal of the American Medical Association and the other in the British Medical Journal, showed that both former and current Levaquin use can cause injuries to the aorta, particularly aortic aneurysm and aortic dissection.
The aorta is the largest artery in the body, supplying oxygenated blood to the entire circulatory system. Its walls have multiple layers, each of which function in different ways to maintain a working circulatory system. An aortic aneurysm is when a section of the aortic wall becomes weakened, allowing it to bulge and slowly grow over time. This aortic aneurysm can eventually rupture, leaving to sometimes fatal internal bleeding. Repairing an aortic aneurysm can require open chest surgery and generally requires the patient undergo the same post-surgery recovery and lifestyle changes of someone having undergone heart surgery.
An aortic dissection is when the inner layer of the aorta tears and the blood pushing through that tear results in a dissection, or separation, of the middle and outer layers. The resulting internal bleeding can result in a loss of blood to vital organs such as the kidneys and heart.
Both of the medical studies published in 2015 demonstrated that persons with a history of Levaquin usage were 50% more likely to suffer from an aortic aneurysm or aortic dissection. The makers of these drugs failed to warn consumers of this risk, exposing hundreds of thousands of Americans to a serious medical condition while they made billions of dollars from their sale.
Individuals and the family members of persons who have been diagnosed with an aortic aneurysm, aortic dissection or damage to the aortic valve in the heart may be entitled to real compensation through Levaquin aortic injury lawsuit. Our attorneys provide free Levaquin claim reviews, and will be happy to answer your questions and help you to understand your legal options. All Levaquin aortic injury lawsuit services are provided on a contingency basis, meaning there are no legal fees unless we win compensation on your behalf.
Filing a lawsuit is the best means for individual consumers to hold pharmaceutical companies accountable for harmful products. By placing profit motives ahead of consumer safety, the maker of Levaquin has caused undue harm and loss to Americans and their families while lining their own pockets. Negligent and unscrupulous pharmaceutical companies can and should be held accountable for their actions, and injured consumers have a right to seek justice. Filing Levaquin aortic injury lawsuit enables consumers to hold the companies accountable for the safety of their products.
The Onder Law Firm has a national reputation for its work in family and consumer safety based on an ethic of hard work, reliable advice, and achieving results on behalf of our clients. We will work tirelessly to ensure each of our clients has trustworthy and excellent legal representation. Contact our attorneys to ensure you have an experienced advocate fighting on behalf of your family.
Whether you choose or firm to represent you or not, we are here to help. From offering free, no-obligation case reviews to providing contingency representation, we never charge a fee unless we win for you. Choosing an attorney is a significant decision and it is our goal to support you with information and expertise as you make your decision. Contact our firm today to speak with an experienced Levaquin aortic injury attorney.
To speak with a lawyer handling Levaquin aortic aneurysm and aortic dissection lawsuits, contact our firm today.
Scott G Williams MD, FACOG
Dr Williams is a board certified obstetrician/gynecologist who serves as chief medical consultant for Onder Law. During more than 20 years as a practicing ob/gyn in St Charles county, Dr Williams delivered thousands of babies, performed surgery on a daily basis, and was considered one of the top providers in his profession. He served as chief of ob/gyn at two of the three hospitals in St Charles county, and currently is the full time medical director of St Louis area obstetric hospitalist program.
In addition, Dr Williams has served as a long time consultant in medical and pharmaceutical litigation for Onder Law. With a background that includes scientific research as well as medical practice, Dr Williams is adept at interpreting pharmaceutical and medical device studies. His past analyses have included research on the harmful effects of contraceptive devices, talc/ ovarian cancer and the blood clotting effects of certain oral contraceptives.
Clients would not commonly meet with Dr Williams as he is not an attorney, but his expertise forms an important part of Onder Law's client strategies for medical and pharmaceutical products. Dr Williams is often a crucial "behind the scenes" part of formulating a winning approach for your case.
Scott G Williams, MD, FACOG, is a 1986 graduate of the University of Notre Dame. His MD was earned at the University of Missouri Columbia and he completed residency at the well regarded University of Florida-Gainesville Ob/Gyn program. Dr Williams and his wife (who is also a physician) live with two labrador retrievers; their son and daughter are at college.